Speaker: Nicole Gormley, MD – U.S. Food and Drug Administration
###Co-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School
### @@@ Kenneth C. Anderson, MD – The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA ### 1395077###Co-Chair###Professor in Medicine###The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA###Co-Chair: Kenneth C. Anderson, MD – The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
###Speaker: Suzanne Lentzsch, MD, PhD (she/her/hers) – Columbia University
### she/her/hersPanelist: Wee Joo Chng, MB ChB, PhD, FRCP (UK), FRCPath (UK), FAMS – National University Cancer Institute, Singapore
### @@@ Sundar Jagannath, MD, FASCO – Mount Sinai Medical Center, New York, NY, USA ### 1395142###Panelist###Chair for Multiple Myeloma and Professor of Medicine###Mount Sinai Medical Center, New York, NY, USA###Panelist: Sundar Jagannath, MD, FASCO – Mount Sinai Medical Center, New York, NY, USA
### @@@ Hira Mian, MD, MSc, FRCPC – McMaster University, Hamilton, Ontario, Canada ### 1719006###Panelist###Assistant Professor###McMaster University, Hamilton, Ontario, Canada###Panelist: Hira Mian, MD, MSc, FRCPC – McMaster University, Hamilton, Ontario, Canada
### @@@ Cristina Gasparetto, MD (she/her/hers) – Department of Medicine, Duke University Cancer Institute, Durham, NC ### 1441876###Panelist###Professor of Medicine###Department of Medicine, Duke University Cancer Institute, Durham, NC###Panelist: Cristina Gasparetto, MD (she/her/hers) – Department of Medicine, Duke University Cancer Institute, Durham, NC
### she/her/hers @@@ Mohamad Mohty, MD, PhD – Sorbonne University, Saint-Antoine Hospital, AP-HP INSERM UMRs 938, Paris, France ### 1395090###Panelist###Professor of Hematology###Sorbonne University, Saint-Antoine Hospital, AP-HP INSERM UMRs 938, Paris, France###Panelist: Mohamad Mohty, MD, PhD – Sorbonne University, Saint-Antoine Hospital, AP-HP INSERM UMRs 938, Paris, France
###Panelist: Jesus G. Berdeja, MD – Sarah Cannon Research Institute
### @@@ Ivan Borrello, MD – Tampa General Hospital ### 1409073###Panelist###Director Multiple Myeloma, BMT and Cell Therapy###Tampa General Hospital###Panelist: Ivan Borrello, MD – Tampa General Hospital
### @@@ Tom Martin, MD (he/him/his) – UCSF ### 1949890###Panelist###Associate Chief, Hematology, Director Blood and Marrow Transplant and Cell Therapy###UCSF###Panelist: Tom Martin, MD (he/him/his) – UCSF
### he/him/his @@@ Monika Engelhardt ### 1949891###Panelist#########Panelist: Monika Engelhardt
### @@@ Sham Mailankody, MBBS – Memorial Sloan Kettering Cancer Center ### 1395111###Panelist###Associate Attending###Memorial Sloan Kettering Cancer Center###Panelist: Sham Mailankody, MBBS – Memorial Sloan Kettering Cancer Center
###Panelist: P. Joy Ho, MBBS DPhil FRACP FRCPA (she/her/hers) – Institute of Haematology, Royal Prince Alfred Hospital
### she/her/hers @@@ Keith Stewart, MB ChB – Princess Margaret Cancer Centre, University Health Network ### 1395117###Panelist###Medical Director, Princess Margaret Cancer Centre and VP Cancer, University Health Network###Princess Margaret Cancer Centre, University Health Network###Panelist: Keith Stewart, MB ChB – Princess Margaret Cancer Centre, University Health Network
### @@@ MELETIOS DIMOPOULOS, MD (he/him/his) – Department of Clinical Therapeutics/Medical School/National and Kapodistrian University of Athens ### 1949885###Panelist###Professor###Department of Clinical Therapeutics/Medical School/National and Kapodistrian University of Athens###Panelist: MELETIOS DIMOPOULOS, MD (he/him/his) – Department of Clinical Therapeutics/Medical School/National and Kapodistrian University of Athens
### he/him/his @@@ Donna E. Reece, MD – University Health Network, Princess Margaret Cancer Centre ### 1395149###Panelist###Professor of Medicine, Director, Clinical Trials Program for Multiple Myeloma and Related Diseases###University Health Network, Princess Margaret Cancer Centre###Panelist: Donna E. Reece, MD – University Health Network, Princess Margaret Cancer Centre
### @@@ Ajai Chari, MD, PhD – University of California, San Francisco ### 1395089###Panelist###Director of Multiple Myeloma Program Professor of Clinical Medicine###University of California, San Francisco###Panelist: Ajai Chari, MD, PhD – University of California, San Francisco
### @@@ Bindu Kanapuru ### 2102754###Panelist#########Panelist: Bindu Kanapuru
###Panelist: Sonja Zweegman, MD, PhD – Amsterdam UMC
### @@@ Herve Avet-Loiseau, MD, PhD (he/him/his) – IUC-Oncopole ### 1395049###Panelist###Head###IUC-Oncopole###Panelist: Herve Avet-Loiseau, MD, PhD (he/him/his) – IUC-Oncopole
### he/him/his @@@ Wilson I. Gonsalves, MD – Mayo Clinic, Rochester ### 1395132###Panelist###Consultant, Division of Hematology, Department of Internal Medicine###Mayo Clinic, Rochester###Panelist: Wilson I. Gonsalves, MD – Mayo Clinic, Rochester
###Panelist: Sergio Giralt, MD – Memorial Sloan Kettering Cancer Center
### @@@ Thierry Facon, MD – University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France ### 1395081###Panelist###Pr###University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France###Panelist: Thierry Facon, MD – University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France
### @@@ Jean-Luc Harousseau, MD – INSTITUT DE CANCEROLOGIE DE L'OUEST FRANCE ### 1395104###Panelist###SCIENTIFIC DIRECTOR###INSTITUT DE CANCEROLOGIE DE L'OUEST FRANCE###Panelist: Jean-Luc Harousseau, MD – INSTITUT DE CANCEROLOGIE DE L'OUEST FRANCE
### @@@ Vania Hungria, MD, PhD – Department of Hematology, Clinica São Germano, São Paulo, Brazil ### 1395161###Panelist###Associate Professor###Department of Hematology, Clinica São Germano, São Paulo, Brazil###Panelist: Vania Hungria, MD, PhD – Department of Hematology, Clinica São Germano, São Paulo, Brazil
### @@@ Michele Cavo (he/him/his) – IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Università degli Studi di Bologna, Bologna, Italy ### 1395079###Panelist###Professor of Haematology###IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Università degli Studi di Bologna, Bologna, Italy###Panelist: Michele Cavo (he/him/his) – IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Università degli Studi di Bologna, Bologna, Italy
### he/him/his @@@ Bindu Kanapuru ### 2102754###Panelist#########Panelist: Bindu Kanapuru
###Panelist: Rafael Fonseca, MD – Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA
### @@@ Andrew Spencer, MBBS FRACP, FRCPA, DM – Alfred Health-Monash University ### 1441802###Panelist###Professor###Alfred Health-Monash University###Panelist: Andrew Spencer, MBBS FRACP, FRCPA, DM – Alfred Health-Monash University
### @@@ Rodger E. Tiedemann, MD, PhD (he/him/his) – Princess Margaret Cancer Centre ### 1395134###Panelist###Senior Scientist, Hematologist###Princess Margaret Cancer Centre###Panelist: Rodger E. Tiedemann, MD, PhD (he/him/his) – Princess Margaret Cancer Centre
### he/him/his @@@ Marta Chesi, PhD (she/her/hers) – Mayo Clinic Arizona ### 1395120###Panelist###Associate Professor###Mayo Clinic Arizona###Panelist: Marta Chesi, PhD (she/her/hers) – Mayo Clinic Arizona
### she/her/hers